Valuation (64%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -44.69 | N/A |
| PEG Ratio (TTM) | 0.26 | N/A |
| P/S Ratio (TTM) | 3.25 | N/A |
| P/B Ratio (TTM) | 4.31 | N/A |
| P/FCF Ratio (TTM) | 26.86 | N/A |
| Price to 5YR AVG Earnings Ratio | 30.65 | N/A |
| Price to 5YR AVG FCF Ratio | 27.30 | N/A |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.66% | N/A |
| ROE (TTM) | -8.06% | N/A |
| Net Profit Margin (TTM) | -7.36% | N/A |
| ROIC 5YR AVG | 10.40% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -258.33% | 55.38% | 26.25% |
| Revenue | 3.17% | 1.95% | 2.27% |
| Net Income | -256.46% | 54.03% | 22.69% |
| Cash Flow | 387.92% | 21.41% | 13.85% |
Health (60%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.14 | N/A |
| Quick Ratio (TTM) | 1.14 | N/A |
| D/E Ratio (TTM) | 0.71 | N/A |
| Interest Coverage (TTM) | 2.84 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.28 | N/A |
| LTL to 5YR AVG FCF | 4.43 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.21% | N/A |